Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kura Oncology Inc shares valued at $231,931 were sold by Burrows Francis on Dec 18 ’25. At $9.78 per share, Burrows Francis sold 23,726 shares. The insider’s holdings dropped to 33,735 shares worth approximately $0.32 million following the completion of this transaction.
Also, FRANCIS J BURROWS purchased 23,726 shares, netting a total of over 231,934 in proceeds.
Before that, Hasnain Faheem had sold 10,000 shares from its account. In a trade valued at $109,764, the Director traded Kura Oncology Inc shares for $10.98 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.22 million.
As published in their initiating research note from Guggenheim on September 04, 2025, Kura Oncology Inc [KURA] has been a Neutral. Analysts at BTIG Research downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early February. As of October 24, 2024, UBS has initiated its “Buy” rating for KURA. Earlier on October 14, 2024, Stifel downgraded its rating. Their new recommendation was “a Hold” for KURA stock which previously was a “a Buy”.
Analyzing KURA Stock Performance
On last trading session, Kura Oncology Inc [NASDAQ: KURA] rose 1.63% to $9.36. The stock’s lowest price that day was $9.01, but it reached a high of $9.425 in the same session. During the last five days, there has been a drop of approximately -6.12%. Over the course of the year, Kura Oncology Inc shares have jumped approximately 29.28%.
Is Kura Oncology Inc subject to short interest?
Stocks of Kura Oncology Inc saw a sharp rise in short interest on 2025-12-31 jumping by 3.32 million shares to 11.31 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 7.99 million shares. A jump of 29.35% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.79 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.79.
Which companies own the most shares of Kura Oncology Inc (KURA)?
In terms of Kura Oncology Inc share price expectations, FactSet research, analysts set an average price target of 33 in the next 12 months, up nearly 258.31% from the previous closing price of $9.21. Analysts anticipate Kura Oncology Inc stock to reach 40 by 2026, with the lowest price target being 20. In spite of this, 3 analysts ranked Kura Oncology Inc stock as Buy at the end of 2026. On December 22, 2023, Mizuho assigned a price target of “a Buy” to the stock and initiated coverage with a $26.
